IGFBP7 and acute kidney injury: The 0.3 cutoff value chosen to define a significant increase in [TIMP-2]·[IGFBP-7] after CM infusion has been only proposed previously as an absolute value to assess the risk of AKI, in studies not specifically addressing CA-AKI [16].